Systematic review
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review

https://doi.org/10.1016/j.cmi.2021.06.015Get rights and content
Under an Elsevier user license
open archive

Abstract

Background

Coronavirus disease 2019 (COVID-19) has been implicated in a wide spectrum of cardiac manifestations following the acute phase of the disease.

Objectives

To assess the range of cardiac sequelae after COVID-19 recovery.

Data sources

PubMed, Embase, Scopus (inception through 17 February 2021) and Google scholar (2019 through 17 February 2021).

Study eligibility criteria

Prospective and retrospective studies, case reports and case series.

Participants

Adult patients assessed for cardiac manifestations after COVID-19 recovery.

Exposure

Severe acute respiratory syndrome coronavirus 2 infection diagnosed by PCR.

Methods

Systematic review.

Results

Thirty-five studies (fifteen prospective cohort, seven case reports, five cross-sectional, four case series, three retrospective cohort and one ambidirectional cohort) evaluating cardiac sequelae in 52 609 patients were included. Twenty-nine studies used objective cardiac assessments, mostly cardiac magnetic resonance imaging (CMR) in 16 studies, echocardiography in 15, electrocardiography (ECG) in 16 and cardiac biomarkers in 18. Most studies had a fair risk of bias. The median time from diagnosis/recovery to cardiac assessment was 48 days (1–180 days). Common short-term cardiac abnormalities (<3 months) included increased T1 (proportion: 30%), T2 (16%), pericardial effusion (15%) and late gadolinium enhancement (11%) on CMR, with symptoms such as chest pain (25%) and dyspnoea (36%). In the medium term (3–6 months), common changes included reduced left ventricular global longitudinal strain (30%) and late gadolinium enhancement (10%) on CMR, diastolic dysfunction (40%) on echocardiography and elevated N-terminal proB-type natriuretic peptide (18%). In addition, COVID-19 survivors had higher risk (risk ratio 3; 95% CI 2.7–3.2) of developing heart failure, arrythmias and myocardial infarction.

Conclusions

COVID-19 appears to be associated with persistent/de novo cardiac injury after recovery, particularly subclinical myocardial injury in the earlier phase and diastolic dysfunction later. Larger well-designed and controlled studies with baseline assessments are needed to better measure the extent of cardiac injury and its clinical impact.

Keywords

Cardiac sequelae
COVID-19
Coronavirus
Heart injury
Long COVID-19
Post-acute COVID-19
SARS-CoV-2

Cited by (0)

Members of the Monaldi Hospital Cardiovascular Infection Study Group are listed in Appendix section.